Santiago J Assaf1, Daniel V Chang1, Christina J Tiller1, Jeffrey A Kisling1, Jamie Case2,3,4, Julie A Mund2,3,4, James E Slaven5, Zhangsheng Yu5, Shawn K Ahlfeld2,4, Brenda Poindexter2, Laura S Haneline2,3,4,6, David A Ingram2,4,7, Robert S Tepper1,4. 1. James Whitcomb Riley Hospital for Children Department of Pediatrics, Sections of Pulmonology, Indiana University School of Medicine, Indianapolis, Indiana. 2. James Whitcomb Riley Hospital for Children Department of Pediatrics, Section of Neonatology, Indiana University School of Medicine, Indianapolis, Indiana. 3. James Whitcomb Riley Hospital for Children Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana. 4. Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana. 5. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana. 6. Departments of Microbiology and Immunology and Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana. 7. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.
Abstract
RATIONALE: While infants who are born extremely premature and develop bronchopulmonary dysplasia (BPD) have impaired alveolar development and decreased pulmonary diffusion (DLCO), it remains unclear whether infants born less premature and do not develop BPD, healthy premature (HP), have impaired parenchymal development. In addition, there is increasing evidence that pro-angiogenic cells are important for vascular development; however, there is little information on the relationship of pro-angiogenic cells to lung growth and development in infants. OBJECTIVE: and Methods Determine among healthy premature (HP) and fullterm (FT) infants, whether DLCO and alveolar volume (VA) are related to gestational age at birth (GA), respiratory support during the neonatal period (mechanical ventilation [MV], supplemental oxygen [O2], continuous positive airway pressure [CPAP]), and pro-angiogenic circulating hematopoietic stem/progenitor cells (CHSPCs). We measured DLCO, VA, and CHSPCs in infants between 3-33 months corrected-ages; HP (mean GA = 31.7 wks; N = 48,) and FT (mean GA = 39.3 wks; N =88). RESULT: DLCO was significantly higher in HP than FT subjects, while there was no difference in VA , after adjusting for body length, gender, and race. DLCO and VA were not associated with GA, MV and O2; however, higher values were associated with higher CHSPCs, as well as treatment with CPAP. CONCLUSION: Our findings suggest that in the absence of extreme premature birth, as well as BPD, prematurity per se, does not impair lung parenchymal development.
RATIONALE: While infants who are born extremely premature and develop bronchopulmonary dysplasia (BPD) have impaired alveolar development and decreased pulmonary diffusion (DLCO), it remains unclear whether infants born less premature and do not develop BPD, healthy premature (HP), have impaired parenchymal development. In addition, there is increasing evidence that pro-angiogenic cells are important for vascular development; however, there is little information on the relationship of pro-angiogenic cells to lung growth and development in infants. OBJECTIVE: and Methods Determine among healthy premature (HP) and fullterm (FT) infants, whether DLCO and alveolar volume (VA) are related to gestational age at birth (GA), respiratory support during the neonatal period (mechanical ventilation [MV], supplemental oxygen [O2], continuous positive airway pressure [CPAP]), and pro-angiogenic circulating hematopoietic stem/progenitor cells (CHSPCs). We measured DLCO, VA, and CHSPCs in infants between 3-33 months corrected-ages; HP (mean GA = 31.7 wks; N = 48,) and FT (mean GA = 39.3 wks; N =88). RESULT: DLCO was significantly higher in HP than FT subjects, while there was no difference in VA , after adjusting for body length, gender, and race. DLCO and VA were not associated with GA, MV and O2; however, higher values were associated with higher CHSPCs, as well as treatment with CPAP. CONCLUSION: Our findings suggest that in the absence of extreme premature birth, as well as BPD, prematurity per se, does not impair lung parenchymal development.
Authors: Daniel V Chang; Christina J Tiller; Jeffrey A Kisling; Jamie Case; Julie A Mund; Laura S Haneline; David A Ingram; Robert S Tepper Journal: Eur Respir J Date: 2013-05-16 Impact factor: 16.671
Authors: M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman Journal: Am J Physiol Lung Cell Mol Physiol Date: 2000-09 Impact factor: 5.464
Authors: Mar Janna Dahl; Sydney Bowen; Toshio Aoki; Andrew Rebentisch; Elaine Dawson; Luke Pettet; Haleigh Emerson; Baifeng Yu; Zhengming Wang; Haixia Yang; Chong Zhang; Angela P Presson; Lisa Joss-Moore; Donald M Null; Bradley A Yoder; Kurt H Albertine Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-09-13 Impact factor: 5.464
Authors: Ryan Lam; Diane Schilling; Brian Scottoline; Astrid Platteau; Meike Niederhausen; Kelli C Lund; Robert L Schelonka; Kelvin D MacDonald; Cindy T McEvoy Journal: J Pediatr Date: 2019-09-10 Impact factor: 4.406